Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes

Introduction. Heparin-induced thrombocytopenia (HIT) is a serious complication seen in hospitalized, medically-ill patients. Evaluation for HIT using a commercially-available ELISA-based test has become increasingly common; however, it does have a high false positive rate. Implications of HIT testin...

Full description

Bibliographic Details
Main Authors: Karlyn Martin, Leila Kia, Neehar D. Parikh, Laura Kulik, Brandon McMahon
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119312554
_version_ 1818741457374150656
author Karlyn Martin
Leila Kia
Neehar D. Parikh
Laura Kulik
Brandon McMahon
author_facet Karlyn Martin
Leila Kia
Neehar D. Parikh
Laura Kulik
Brandon McMahon
author_sort Karlyn Martin
collection DOAJ
description Introduction. Heparin-induced thrombocytopenia (HIT) is a serious complication seen in hospitalized, medically-ill patients. Evaluation for HIT using a commercially-available ELISA-based test has become increasingly common; however, it does have a high false positive rate. Implications of HIT testing in patients with cirrhosis have not yet been reported.Material and methods. We conducted a single-institution, retrospective review of all patients with cirrhosis admitted over a 29-month period. The student’s t-test and the χ2 test were used for comparisons. We performed a stratified survival analysis using Kaplan-Meier and log rank testing.Results. A total of 1,305 patients had a HIT Ab sent during the study period. Of these patients, 106 had cirrhosis and were included in the study. Eighteen (17%) of the patients with cirrhosis were HIT Ab positive and four of the eighteen had a positive Serotonin Release Assay (SRA) confirmatory test. No difference was found in platelet nadir, thrombotic rate, length of stay, and patient survival between patients with positive HIT Ab and negative HIT Ab testing. No consistent treatment was used among patients who were HIT Ab positive, despite hematology service consultation. Patients who were HIT Ab negative were more likely to have undergone liver transplantation compared to those who were positive (27 vs. 5.5%, respectively; p = 0.048).Conclusion. Our data suggest that HIT Ab testing is over-used in patients with cirrhosis and is poorly predictive of outcomes. With a poor positive predictive value, HIT testing may add unnecessary complexity to an already complicated patient population.
first_indexed 2024-12-18T01:56:56Z
format Article
id doaj.art-7582c5b813514e82b3998d06e1f3bd24
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-12-18T01:56:56Z
publishDate 2014-09-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-7582c5b813514e82b3998d06e1f3bd242022-12-21T21:24:54ZengElsevierAnnals of Hepatology1665-26812014-09-01135548554Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomesKarlyn Martin0Leila Kia1Neehar D. Parikh2Laura Kulik3Brandon McMahon4Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. U.S.ADepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. U.S.ADivision of Gastroenterology, Department of Medicine, University of Michigan Health System, Ann Arbor, MI. U.S.A; Correspondence and reprint request:Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago IL. U.S.ADivision of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago. IL. U.S.AIntroduction. Heparin-induced thrombocytopenia (HIT) is a serious complication seen in hospitalized, medically-ill patients. Evaluation for HIT using a commercially-available ELISA-based test has become increasingly common; however, it does have a high false positive rate. Implications of HIT testing in patients with cirrhosis have not yet been reported.Material and methods. We conducted a single-institution, retrospective review of all patients with cirrhosis admitted over a 29-month period. The student’s t-test and the χ2 test were used for comparisons. We performed a stratified survival analysis using Kaplan-Meier and log rank testing.Results. A total of 1,305 patients had a HIT Ab sent during the study period. Of these patients, 106 had cirrhosis and were included in the study. Eighteen (17%) of the patients with cirrhosis were HIT Ab positive and four of the eighteen had a positive Serotonin Release Assay (SRA) confirmatory test. No difference was found in platelet nadir, thrombotic rate, length of stay, and patient survival between patients with positive HIT Ab and negative HIT Ab testing. No consistent treatment was used among patients who were HIT Ab positive, despite hematology service consultation. Patients who were HIT Ab negative were more likely to have undergone liver transplantation compared to those who were positive (27 vs. 5.5%, respectively; p = 0.048).Conclusion. Our data suggest that HIT Ab testing is over-used in patients with cirrhosis and is poorly predictive of outcomes. With a poor positive predictive value, HIT testing may add unnecessary complexity to an already complicated patient population.http://www.sciencedirect.com/science/article/pii/S1665268119312554SurvivalThrombosisHITTransplantation
spellingShingle Karlyn Martin
Leila Kia
Neehar D. Parikh
Laura Kulik
Brandon McMahon
Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
Annals of Hepatology
Survival
Thrombosis
HIT
Transplantation
title Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
title_full Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
title_fullStr Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
title_full_unstemmed Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
title_short Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
title_sort heparin induced thrombocytopenia testing is over utilized in cirrhosis amp correlates with poor clinical outcomes
topic Survival
Thrombosis
HIT
Transplantation
url http://www.sciencedirect.com/science/article/pii/S1665268119312554
work_keys_str_mv AT karlynmartin heparininducedthrombocytopeniatestingisoverutilizedincirrhosisampcorrelateswithpoorclinicaloutcomes
AT leilakia heparininducedthrombocytopeniatestingisoverutilizedincirrhosisampcorrelateswithpoorclinicaloutcomes
AT neehardparikh heparininducedthrombocytopeniatestingisoverutilizedincirrhosisampcorrelateswithpoorclinicaloutcomes
AT laurakulik heparininducedthrombocytopeniatestingisoverutilizedincirrhosisampcorrelateswithpoorclinicaloutcomes
AT brandonmcmahon heparininducedthrombocytopeniatestingisoverutilizedincirrhosisampcorrelateswithpoorclinicaloutcomes